×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sobi To Acquire CTI BioPharma In $1.7B Deal
Contract Pharma
The transaction is expected to diversify Sobi's portfolio of leading hematology medicines through CTI's lead product, VONJO.
7 months ago
Should You Buy CTI BioPharma (CTIC) After Golden Cross?
Yahoo Movies UK
CTI BioPharma Corp. (CTIC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support.
2 weeks ago
Sobi and CTI BioPharma Complete $1.7 Billion Acquisition Deal
PharmTech
Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at...
10 months ago
CTI BioPharma Stock Soars on Deal to Be Acquired for $1.7 Billion
Barron's
Swedish Orphan Biovitrum (ticker: SOBI.Sweden), also called Sobi, will buy CTI (CTIC) for $9.10 a share in cash, representing an implied equity...
12 months ago
Former Gibson Dunn visiting lawyer charged with insider trading on pharma deal
Reuters
A Brazilian lawyer who was working for Gibson, Dunn & Crutcher as a visiting attorney was charged on Wednesday with insider trading after...
9 months ago
Interim report Q2 2023
Sobi
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2023. Second quarter 2023.
10 months ago
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
PR Newswire
Growing physician awareness and usage of VONJO® (pacritinib) drove quarterly double-digit revenue growth – – VONJO® net product revenue...
14 months ago
Latham Watkins Advises Sobi in Acquisition of CTI BioPharma Corp
Latham & Watkins LLP
Latham & Watkins Advises Sobi in Acquisition of CTI BioPharma Corp. ... Cross-border team represents biopharmaceutical company in transaction to...
12 months ago
DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp.
Canada Newswire
("CTI") has prepaid all amounts outstanding under the credit facility it entered into with a wholly-owned subsidiary of the Trust, resulting in...
10 months ago
CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo
Fierce Pharma
CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo ... It's been a long and tortuous path to approval...
26 months ago